Tech Company Financing Transactions

USGI Medical Funding Round

Private investors invested in a $19.5 million funding round for USGI Medical. The round was announced on 1/27/2015.

Transaction Overview

Company Name
Announced On
1/27/2015
Transaction Type
Debt
Venture Equity
Amount
$19,500,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding provides USGI with the capital resources to extend the commercial launch of POSE (Primary Obesity Surgery, Endolumenal) in Europe and the Middle East and begin pre-commercialization activities for the procedure in the U.S., as the company completes the follow-up phase of its U.S. pivotal study known as ESSENTIAL, and prepares to submit an application to FDA for approval. This money will also fund the crossover study as part of the ESSENTIAL trial, health economics research and several important studies in Europe.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1140 Calle Cordillera
San Clemente, CA 92673
USA
Email Address
Overview
USGI Medical is the pioneer in the development of Incisionless EndoSurgery technology. Our EndoSurgical Operating System will allow complex surgical procedures to be performed using only the natural passageways of the GI tract for access.
Profile
USGI Medical LinkedIn Company Profile
Social Media
USGI Medical Company Twitter Account
Company News
USGI Medical News
Facebook
USGI Medical on Facebook
YouTube
USGI Medical on YouTube

Management Team

Title
Name
Email & Social
Chairman
Scott Moonly
  Scott Moonly LinkedIn Profile  Scott Moonly Twitter Account  Scott Moonly News  Scott Moonly on Facebook
Chief Executive Officer
Carlos Babini
  Carlos Babini LinkedIn Profile  Carlos Babini Twitter Account  Carlos Babini News  Carlos Babini on Facebook
Chief Operating Officer
Tracy Maahs
  Tracy Maahs LinkedIn Profile  Tracy Maahs Twitter Account  Tracy Maahs News  Tracy Maahs on Facebook
VP - Engineering
Chris Earley
  Chris Earley LinkedIn Profile  Chris Earley Twitter Account  Chris Earley News  Chris Earley on Facebook
VP - Marketing
Kevin Condrin
  Kevin Condrin LinkedIn Profile  Kevin Condrin Twitter Account  Kevin Condrin News  Kevin Condrin on Facebook
VP - Sales
Chris Klecher
  Chris Klecher LinkedIn Profile  Chris Klecher Twitter Account  Chris Klecher News  Chris Klecher on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/27/2015: Xolve venture capital transaction
Next: 1/27/2015: Xenex Disinfection Services venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary